The Therapeutics Accelerator is committing funding to speed the response to the COVID-19 epidemic by playing a catalytic role in accelerating the evaluation of new and repurposed drugs and biologics to treat patients with COVID-19. The Therapeutics Accelerator is a collaborative effort committed to equitable access, including making products available and affordable in low-resource settings.
This portal is provided for applicants to propose diagnostics approaches to enable effective interventions. The process begins with an application form and a screening questionnaire. The screening questionnaire is then reviewed, resulting in either a request for additional information, deferring, or advancing. If the submission advances, then the submitter will be requested to complete a full proposal questionnaire. This will enable a rigorous and standardized review and subsequent discussion of a proposed diagnostic.
Please note that each proposal should be in line with the Therapeutics Accelerator’s guiding principles in order to qualify for review. We have highlighted the most relevant criteria here:
- A focus on near-term impact
- Global access through prompt launch, with a focus on vulnerable populations
- Feasibility for use in low- and middle-income (LMIC) health systems
- A willingness to share relevant data in near real-time
For more info and submission, you can visit their website at: https://submit.gatesfoundation.org/prog/covid-19_therapeutics_accelerator_diagnostics_proposal_portal/